Ovid Therapeutics Inc (OVID)
3.15
-0.12
(-3.82%)
USD |
NASDAQ |
May 17, 16:00
3.15
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Price: 3.15 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 3.30 | 3.305 | 3.11 | 3.15 | 88873.00 |
| May 16, 2024 | 3.33 | 3.410 | 3.27 | 3.275 | 105233.0 |
| May 15, 2024 | 3.26 | 3.426 | 3.18 | 3.32 | 155063.0 |
| May 14, 2024 | 3.00 | 3.25 | 2.99 | 3.23 | 122743.0 |
| May 13, 2024 | 3.00 | 3.04 | 2.988 | 3.02 | 69595.00 |
| May 10, 2024 | 3.06 | 3.06 | 3.00 | 3.00 | 54455.00 |
| May 09, 2024 | 3.10 | 3.104 | 3.005 | 3.05 | 99248.00 |
| May 08, 2024 | 3.00 | 3.11 | 2.98 | 3.09 | 99242.00 |
| May 07, 2024 | 3.00 | 3.070 | 2.98 | 3.00 | 98708.00 |
| May 06, 2024 | 3.02 | 3.138 | 2.98 | 3.02 | 101375.0 |
| May 03, 2024 | 3.17 | 3.17 | 3.00 | 3.06 | 77179.00 |
| May 02, 2024 | 3.09 | 3.12 | 3.03 | 3.07 | 67143.00 |
| May 01, 2024 | 3.05 | 3.12 | 2.911 | 3.06 | 222034.0 |
| Apr 30, 2024 | 3.39 | 3.45 | 3.04 | 3.05 | 240074.0 |
| Apr 29, 2024 | 3.20 | 3.36 | 3.145 | 3.34 | 311343.0 |
| Apr 26, 2024 | 2.99 | 3.13 | 2.99 | 3.10 | 80529.00 |
| Apr 25, 2024 | 3.13 | 3.14 | 2.99 | 2.99 | 112117.0 |
| Apr 24, 2024 | 3.18 | 3.216 | 3.11 | 3.15 | 113127.0 |
| Apr 23, 2024 | 3.16 | 3.244 | 3.11 | 3.20 | 110579.0 |
| Apr 22, 2024 | 3.23 | 3.29 | 3.12 | 3.15 | 205940.0 |
| Apr 19, 2024 | 3.19 | 3.29 | 3.17 | 3.23 | 176642.0 |
| Apr 18, 2024 | 3.12 | 3.24 | 3.12 | 3.21 | 226932.0 |
| Apr 17, 2024 | 3.18 | 3.22 | 3.05 | 3.11 | 160465.0 |
| Apr 16, 2024 | 3.18 | 3.23 | 3.15 | 3.17 | 138008.0 |
| Apr 15, 2024 | 3.21 | 3.24 | 3.198 | 3.20 | 131931.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.44
Minimum
Nov 07 2022
8.24
Maximum
Aug 19 2020
3.360
Average
3.29
Median
Feb 03 2021
Price Benchmarks
| Ligand Pharmaceuticals Inc | 86.06 |
| NovaBay Pharmaceuticals Inc | 0.1186 |
| Palatin Technologies Inc | 2.00 |
| iBio Inc | 1.98 |
| Theriva Biologics Inc | 0.3707 |
Price Related Metrics
| PS Ratio | 469.90 |
| Price to Book Value | 2.855 |
| Earnings Yield | -23.17% |
| Market Cap | 223.48M |